HPV Linked to Squamous Cell Carcinoma (CME/CE)

Vaccine Eyed for Early-Stage Prostate Ca
SAN FRANCISCO (MedPage Today) -- The immunotherapy agent sipuleucel-T (Provenge) appears safe for use earlier in prostate cancer, researchers found.

FDA approves Roche skin cancer drug Erivedge
NEW YORK (AP) -- Federal regulators on Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma....

FDA approves Roche skin cancer drug Erivedge
FDA approves Roche skin cancer drug Erivedge NEW YORK (AP) — Federal regulators on Monday approved a pill that treats the most common type of skin cancer, basal cell carcinoma. The most...

The Unwritten Rules of Friendship: Simple Strategies...
"Nobody likes me!" is a complaint that parents hear all too often, and few utterances make them feel more helpless. Now help is at hand: This practical and compassionate guidebook enables...

Burt's Bees Free Head to Toe Starter Kit